RankAlpha logo
Back to Rankings

JANX

Janux TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
JANX vs peer average
44/100
JANX vs. peer average (D vs. D)
Grade spread
B 2 · C 1 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

LXRX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $839.53M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerLXRXLexicon
JANX
Janux Therapeutics
LXRX
Lexicon
Grade
D
D
Momentum
24
50
Value
58
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs LXRX

JANX / LXRX
Grade Position
Below peers
JANX vs. peer average (D vs. D)
44/100
Momentum
24
LXRX
Value
58
JANX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs JANX
1
LXRX
Lexicon Pharmaceuticals Inc Common
D
40/100
Even
2
ABUS
Arbutus Biopharma Corp Common
B
80/100
-2
3
IVA
Inventiva SA ADR
F
20/100
+1
4
XNCR
Xencor Inc Common
F
20/100
+1
5
MGTX
MeiraGTx Holdings Plc Common
D
40/100
Even
LXRX is the first peer returned for this comparison set.